You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclosporins

Showing 51 - 75 of 754
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Syndromes Trial (Oph1, Restasis)

Not yet recruiting
  • Dry Eye Syndromes
  • (no location specified)
Jan 7, 2022

Pharmacological Action Trial (Rituximab, Dexamethasone)

Not yet recruiting
  • Pharmacological Action
  • (no location specified)
Sep 22, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

COVID-19 Trial in Philadelphia (Cyclosporine)

Completed
  • COVID-19
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 7, 2022

Atopic Dermatitis Trial in Madrid (Cyclosporin A, Follow-up of Cyclospoin treatment already started)

Recruiting
  • Atopic Dermatitis
  • Cyclosporin A
  • Follow-up of Cyclospoin treatment already started
  • Madrid, Spain
    Hospital La Paz
Jan 11, 2023

Aplastic Anemia Trial in Beijing (Luspatercept)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
May 30, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Corticosteroid Combining Noncorticosteroid Systemic

Recruiting
  • Vogt Koyanagi Harada Disease (VKH)
  • noncorticosteroid systemic immunomodulatory therapy (NCSIT)
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Nov 3, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Epidermolysis Bullosa Trial in Minneapolis (drug, procedure, radiation)

Active, not recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center and Medical Center
Feb 25, 2022

Takotsubo Cardiomyopathy Trial in Germany (Cyclosporine A, Placebo)

Not yet recruiting
  • Takotsubo Cardiomyopathy
  • Cyclosporine A
  • Placebo
  • Bad Nauheim, Germany
  • +30 more
Jul 7, 2023

Hepatitis C Trial (Cyclosporine, Tacrolimus)

Completed
Has Results
  • Hepatitis C
  • (no location specified)
Feb 14, 2022

Healthy Volunteer Study Trial in Montreal (AT-527 550 mg + cyclosporine)

Completed
  • Healthy Volunteer Study
  • AT-527 550 mg + cyclosporine
  • Montreal, Quebec, Canada
    Atea Study Site
Jul 27, 2021

Dry Eye Trial in Nashville (nanomicellular cyclosporine 0.09%, Lifitegrast)

Recruiting
  • Dry Eye
  • Nashville, Tennessee
    Toyos Clinic
Oct 4, 2021

HIV Trial in United States (Cyclosporine)

Completed
  • HIV Infections
  • San Francisco, California
  • +11 more
Oct 27, 2021

Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jul 14, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

Renal Allograft Recipients Trial in Worldwide (Belatacept, Tacrolimus, Cyclosporine A)

Recruiting
  • Renal Allograft Recipients
  • Belatacept
  • +5 more
  • Birmingham, Alabama
  • +14 more
Oct 24, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Cyclosporine, Pharmacokinetic

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium

Completed
  • Dry Eye Disease
  • SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
  • +6 more
  • Phoenix, Arizona
  • +39 more
Apr 10, 2022

Severe Aplastic Anemia (SAA) Trial in Worldwide (eltrombopag, rabbit anti-thymocyte globulin (r-ATG), cyclosporine A (CsA))

Active, not recruiting
  • Severe Aplastic Anemia (SAA)
  • Zhengzhou, Henan, China
  • +11 more
Jan 23, 2023

Hepatitis, Autoimmune, Primary Biliary Cholangitis, Immunosuppression Trial in Chengdu (Cyclosporin A, Mycophenolate Mofetil)

Recruiting
  • Hepatitis, Autoimmune
  • +2 more
  • Cyclosporin A
  • Mycophenolate Mofetil
  • Chengdu, Sichuan, China
    WestChina Hospital
Jun 16, 2021

Bronchiolitis Obliterans, Obliterative Bronchiolitis, Bronchiolitis Obliterans Syndrome Trial in Worldwide (Liposomal

Enrolling by invitation
  • Bronchiolitis Obliterans
  • +2 more
  • Liposomal Cyclosporine A 5 mg
  • Liposomal Cyclosporine A 10 mg
  • San Francisco, California
  • +18 more
Mar 15, 2022